Mirae Asset Healthcare Fund - Regular Plan - IDCW Payout
Mirae Asset Investment Managers (India) Private Limited
₹26.15 (+1.01%)
NAV as of 9 Oct 2026
Minimum Investment: ₹5,000
Return
14.16% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 1.15%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹5,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,168
Invested ₹1,000
▲+16.78%1 year
₹1,142
Invested ₹1,000
▲+14.16%3 years
₹1,194
Invested ₹1,000
▲+19.38%5 years
₹1,123
Invested ₹1,000
▲+12.35%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR INR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +14.16% | +19.38% | +12.35% | — |
| Cumulative returns (%) | +14.16% | +70.14% | +79.00% | — |
Fund Manager
| Manager | Tanmay Mehta |
|---|---|
| Role | Manager |
| Manager Tenure | 1.5 yrs |
About Fund
| Date of Incorporation | 2 Jun 2018 |
|---|---|
| Fund House | Mirae Asset Investment Managers (India) Private Limited |
| Custodian | SBI – SG Securities Pvt. Ltd. |
| Registrar / Transfer Agent | Mirae Asset Investment Managers (India) Private Limited |
| Address | B Wing, Jeevan Seva Annexe Bldg, S V Road,Santacruz (West), Mumbai- 400 054 |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 10.90% |
| Divi's Laboratories Ltd | 9.91% |
| Torrent Pharmaceuticals Ltd | 7.06% |
| J.B. Chemicals & Pharmaceuticals Ltd | 6.49% |
| Apollo Hospitals Enterprise Ltd | 5.91% |
| Laurus Labs Ltd | 5.24% |
| Glenmark Pharmaceuticals Ltd | 4.99% |
| Cipla Ltd | 4.83% |
| Lupin Ltd | 4.13% |
| Dr Reddy's Laboratories Ltd | 3.94% |
| Aurobindo Pharma Ltd | 3.81% |
| Cohance Lifesciences Ltd | 3.56% |
| Alkem Laboratories Ltd | 3.56% |
| Krishna Institute of Medical Sciences Ltd | 3.48% |
| Ipca Laboratories Ltd | 3.43% |
| Fortis Healthcare Ltd | 3.40% |
Investment Strategy
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
To generate long term capital appreciation
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.